Virax Biolabs Group Limited (VRAX)
NASDAQ: VRAX · Real-Time Price · USD
3.110
-0.265 (-7.85%)
At close: Jun 26, 2026, 4:00 PM EDT
3.470
+0.360 (11.58%)
After-hours: Jun 26, 2026, 7:57 PM EDT
Virax Biolabs Group Employees
Virax Biolabs Group had 19 employees as of March 31, 2025. The number of employees increased by 2 or 11.76% compared to the previous year.
Employees
19
Change (1Y)
2
Growth (1Y)
11.76%
Revenue / Employee
$157
Profits / Employee
-$297,031
Market Cap
2.48M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 19 | 2 | 11.76% |
| Mar 31, 2024 | 17 | 6 | 54.55% |
| Mar 31, 2023 | 11 | 6 | 120.00% |
| Mar 31, 2022 | 5 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Calidi Biotherapeutics | 29 |
| VivoSim Labs | 14 |
| Azitra | 13 |
| Decoy Therapeutics | 11 |
| CDT Equity | 4 |
| GRI Bio | 4 |
| SciSparc | 3 |
| Oragenics | 3 |
VRAX News
- 2 days ago - Virax Biolabs Group Ltd trading halted, news pending - TheFly
- 4 days ago - Virax Biolabs approves share consolidation program - TheFly
- 4 days ago - Virax Biolabs Group Limited Announces 1-for-25 Share Consolidation - PRNewsWire
- 4 weeks ago - Virax Biolabs reports pilot data for ViraxImmune in Long COVID - TheFly
- 4 weeks ago - Virax Biolabs Reports Positive Early Clinical Data for ViraxImmune™ in Long COVID and Related Post-Acute Infection Syndromes - PRNewsWire
- 2 months ago - Virax Biolabs CEO outlines strategic priorities, near-term milestones - TheFly
- 2 months ago - Virax Biolabs' CEO James Foster Outlines Strategic Priorities and Near-Term Milestones in Letter to Shareholders - PRNewsWire
- 3 months ago - Virax Biolabs Achieves ISO Certifications, Laying Foundation for Regulated IVD Development and U.S. Clinical Validation - PRNewsWire